Taiwan pharma group quashes damages award in Germany

The German Supreme Court has set aside a €140 million damages award against a Taiwanese pharmaceuticals company after finding the ICC tribunal violated its right to be heard – in a fight over a blood cancer drug that has spawned a second ICC case worth US$5 billion and a criminal complaint.

Get unlimited access to all Global Arbitration Review content